Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Edesa Biotech, Inc. | v426081_ex32-2.htm |
| EX-31.2 - EXHIBIT 31.2 - Edesa Biotech, Inc. | v426081_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Edesa Biotech, Inc. | v426081_ex31-1.htm |
| EX-32.1 - EXHIBIT 32.1 - Edesa Biotech, Inc. | v426081_ex32-1.htm |
| EX-10.20 - EXHIBIT 10.20 - Edesa Biotech, Inc. | v426081_ex10-20.htm |
| EX-10.22 - EXHIBIT 10.22 - Edesa Biotech, Inc. | v426081_ex10-22.htm |
| EX-10.21 - EXHIBIT 10.21 - Edesa Biotech, Inc. | v426081_ex10-21.htm |
| 10-K - FORM 10-K - Edesa Biotech, Inc. | v426081_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-203595) of our report dated December 14, 2015, relating to the consolidated financial statements of Stellar Biotechnologies, Inc., which report appears in this Annual Report on Form 10-K for the year ended September 30, 2015.
/s/ Moss Adams LLP
Los Angeles, California
December 14, 2015